Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macrophage activation and immunometabolism refers to the intrinsic link between a macrophage's metabolic state and its functional phenotype (O'Neill et al., 2016). Upon activation, macrophages undergo metabolic reprogramming to meet the energetic and biosynthetic demands of their specific immune roles (Kelly & O'Neill, 2015). Pro-inflammatory (M1-like) macrophages generally shift toward aerobic glycolysis and a truncated tricarboxylic acid (TCA) cycle, leading to the accumulation of metabolites like succinate and itaconate that further signal inflammatory responses (Mills et al., 2016). Conversely, anti-inflammatory (M2-like) macrophages rely more heavily on oxidative phosphorylation and fatty acid oxidation to support tissue repair and resolution of inflammation (Geeraerts et al., 2017). Dysregulation of these metabolic programs is a hallmark of many diseases, including cancer, where the tumor microenvironment can polarize macrophages to an immunosuppressive state, and atherosclerosis, where metabolic stress drives chronic inflammation (Viola et al., 2019). While not a single molecular target, the pathways governing macrophage immunometabolism are being explored for therapeutic intervention to re-polarize immune cells in various disease contexts.
Modulation of intracellular metabolic pathways, such as glycolysis and the tricarboxylic acid cycle, to shift macrophage functional phenotypes between pro-inflammatory and anti-inflammatory states.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage activation and immunometabolism.